Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D9VE
|
|||
| Former ID |
DNCL001868
|
|||
| Drug Name |
DCCR
|
|||
| Synonyms |
Diazoxide choline controlled-release
Click to Show/Hide
|
|||
| Indication | Prader-Willi syndrome [ICD-11: LD90.3; ICD-10: Q87.1] | Phase 3 | [1] | |
| Dyslipidemia [ICD-11: 5C80-5C81; ICD-9: 272] | Phase 2 | [2] | ||
| Company |
Essentials
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C13H21ClN3O3S+
|
|||
| Canonical SMILES |
CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl.C[N+](C)(C)CCO
|
|||
| InChI |
1S/C8H7ClN2O2S.C5H14NO/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5;1-6(2,3)4-5-7/h2-4H,1H3,(H,10,11);7H,4-5H2,1-3H3/q;+1
|
|||
| InChIKey |
HDPYPMDYNYTKHI-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03440814) A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01211847) Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.